GlaxoSmithKline Recalls Arranon Injection Due to Impurities
GlaxoSmithKline recalls specific lots of Arranon (nelarabine) Injection 5mg/mL vials due to potential impurities exceeding specification limits.
Use caution until it’s fixed
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Contact the company
What happened, in plain English
GlaxoSmithKline LLC is recalling 1,319 vials of Arranon (nelarabine) Injection 5mg/mL because potential drug-related impurities may exceed specification limits. The affected products were distributed nationwide and made in England. The recall was initiated on October 8, 2012. Read more at govinfonow.com/recall/48520-glaxosmithkline-llc-recalls-arranon-nelarabine-injection-5mg-ml-50ml-vials.
Source Summary by GovInfoNow · govinfonow.com/recall/48520-glaxosmithkline-llc-recalls-arranon-nelarabine-injection-5mg-ml-50ml-vials · Updated October 13, 2026 · FDA enforcement record: FDA #D-068-2013
Cite this page
“GlaxoSmithKline Recalls Arranon Injection Due to Impurities.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48520-glaxosmithkline-llc-recalls-arranon-nelarabine-injection-5mg-ml-50ml-vials. Based on FDA recall #D-068-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-068-2013%22&limit=1).
Why it’s dangerous
The vials may contain drug-related impurities that exceed established specification limits. While the record does not detail specific injuries, exceeding impurity limits in a prescription drug poses a potential risk to patient safety during intravenous infusion.
Who’s affected
Patients who have received or are prescribed Arranon (nelarabine) Injection from the specific lots listed below. Healthcare providers administering this IV infusion are also affected.
How to tell if you have this one
Check for Arranon (nelarabine) Injection 5mg/mL in 50mL vials with NDC 0007-4401-06. Look for Lot numbers C536707, C538830, or C533169, all with an expiration date of 02/14.
- Brand
GlaxoSmithKline- Category
Drug
What to do — step by step
Check Product Details
Verify if you have vials with NDC 0007-4401-06 and lot numbers C536707, C538830, or C533169 expiring in February 2014.
Contact Healthcare Provider
If you have the recalled product, contact your healthcare provider or pharmacist immediately for guidance on what to do next.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 23 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many vials are being recalled?
A total of 1,319 vials are included in this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-068-2013 (October 8, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-068-2013 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.